Evaluación funcional cardiovascular en hipertensos tratados con Enalapril durante 6 meses

Ruiz Gutiérrez, Rita del C; Cabrera Rojo, Iliana; Capdevila Pérez, Vladimir; Rodríguez Martorell, Francisco.
CorSalud ; 4(3)2012. tab, graf
Artículo en Español | CUMED | ID: cum-55007

Documentos relacionados

  1. The Influence of Structural Variants of the <i>CES1</i> Gene on the Pharmacokinetics of Enalapril, Presumably Due to Linkage Disequilibrium with the Intronic rs2244613.
  2. Effect of Formulation Parameters on Enalapril Maleate Mucoadhesive Buccal Tablet Using Quality by Design (QbD) Approach.
  3. Simultaneous determination of enalapril maleate and nitrendipine in tablets using spectrophotometric methods manipulating ratio spectra.
  4. Effect of CES1 genetic variation on enalapril steady-state pharmacokinetics and pharmacodynamics in healthy subjects.
  5. Orthostatic stress response in pediatric Fontan patients and the effect of ACE inhibition.
  6. Pharmacogenetic markers of development of angioneurotic edema as a secondary side effect to enalapril in patients with essential arterial hypertension.
  7. [Clinical- functional assessment of organoprotective efficacy of enalapril and telmisartan in patients with arterial hypertension].
  8. Effects of losartan and enalapril on serum uric acid and GFR in children with proteinuria.
  9. [Effect of enalapril on apoptosis of renal tubular epithelial cells in renal interstitial fibrosis in rats].
  10. BIOCHEMICAL AND MORPHOLOGICAL MARKERS OF EXPERIMENTAL SCOPOLAMINE-INDUCED NEURODEGENERATION AND THE EFFECT OF ENALAPRIL ON THEM.